Recalcitrant warts, associated with natural killer cell dysfunction, treated with systemic IFN-alpha.
Cac
Natalie N
NN
Ballas
Zuhair K
ZK
D000998:Antiviral Agents / Q000627:therapeutic use*; D019002:CD56 Antigen / Q000276:immunology; D005260:Female; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D007694:Killer Cells, Natural / Q000276:immunology*; D008875:Middle Aged; D011994:Recombinant Proteins; D014860:Warts / Q000188:drug therapy* / Q000276:immunology
D000998:Antiviral Agents; D019002:CD56 Antigen; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins